Nyheder og presseoversigt

Nyheder og presseoversigt

Her kan du finde de seneste nyheder om Italfarmaco Nordics og virksomhedens presseanmeldelser.

  • 2024 - September 6

    Verdens Duchenne Bevidsthedsdag 2024

    Den 7. september markeres World Duchenne Awareness Day (WDAD), en sygdom, hvor vi som virksomhed er særligt engagerede.

Press review

2024 – March 21

Business Wire

Italfarmaco receives FDA approval for givinostat in Duchenne muscular dystrophy (DMD)

Read the article

2024 – March 19

Business Wire

Italfarmaco Publishes in The Lancet Neurology results from Phase 3 EPIDYS Study in Duchenne Muscular Dystrophy (DMD)

Read the article

2023 – September 05

Business Wire

Italfarmaco Group Receives EMA Validation of Marketing Authorization Application for Givinostat in Duchenne Muscular Dystrophy

Read the article

2023 – June 29

Business Wire

Italfarmaco Group Completes FDA Submission of New Drug Application for Givinostat in Duchenne Muscular Dystrophy and Receives Priority Review

Read the article

2022 – June 25

Business Wire

Italfarmaco Group Announces Positive Topline Data from Phase 3 Trial Showing Beneficial Effect of Givinostat in Patients with Duchenne Muscular Dystrophy

Read the article